| Issue Date | Title | Author(s) |
| 2021 | 3D organotypic cell structures for drug development and Microorganism-Host interaction research | Zubareva, E. V.; Nadezhdin, S. V.; Belyaeva, V. S.; Burda, Yu. E.; Avtina, T. V.; Gudyrev, O. S. |
| 2019 | Combination of captopril and darbepoetin alfa attenuate radiation-induced-endothelial dysfunction | Saroyan, K. V.; Sytnik, M. V.; Miller, E. S.; Puchenkova, O. A.; Soldatov, V. O.; Gashevskaya, A. S.; Artyushkova, E. B.; Gudyrev, O. S. |
| 2020 | Comparative study of the pharmacological effects of Venarus Plus, Venarus, and Detralex on L-NAME-induced endothelial dysfunction, venous tone and platelet aggregation | Lukyanova, Y. S.; Gureev, V. V.; Kolesnichenko, P. D.; Danilenko, L. M.; Gudyrev, O. S.; Pokrovskaya, T. G. |
| 2020 | Eleven-amino acid peptides that mimic the erythropoietin α-helix B increases cell survival in endotheliocyte culture | Antsiferov, O. V.; Korokin, M. V.; Gureev, V. V.; Pokrovskii, M. V.; Korokina, L. V.; Gudyrev, O. S.; Pokrovskaia, T. G. |
| 2018 | Evaluation of carbamylated darbepoetin acute toxicity | Kolesnichenko, P. D.; Gudyrev, O. S.; Zhuchenko, M. A.; Zhernakova, N. I.; Faitelson, A. V. |
| 2019 | Integrated evaluation of the endothelioprotective activity of an innovative peptide simulating the alpha-helix of B-erythropoethin in L-name-induced nitrogen oxide deficiency at the late gestation period | Pokrovskii, M. V.; Yurakova, A. V.; Gureev, V. V.; Golubev, I. V.; Lokteva, T. I.; Korokin, M. V.; Gudyrev, O. S.; Pokrovskaia, T. G. |
| 2019 | Mechanism of neuroprotective effect of mGluR4 agonists | Avdeeva, N. V.; Sidorova, S. A.; Gudyrev, O. S.; Osipova, O. A.; Golubev, I. V. |
| 2017 | Pharmacological efficacy of an inhibitor of arginase-2 KUD975 with L-NAME-induced endothelial dysfunction | Kudryavtsev, K. V.; Korokin, M. V.; Gudyrev, O. S. |
| 2018 | Study of endothelio- and osteoprotective effects of combination of rosuvastatin with L-norvaline in experiment | Sobolev, M. S.; Faitelson, A. V.; Gudyrev, O. S.; Rajkumar, D.S.R.; Dubrovin, G. M. |
| 2016 | Study of the influence of L-norvaline, rosuvastatin and their combination on the level of microcirculation in bone tissue in experimental osteoporosis and fractures on its background | Rajkumar, D. S. R.; Gudyrev, O. S.; Faitelson, A. V.; Stepchenko, A. A.; Dolzhikov, A. A. |
| 2015 | Study of the microcirculation level in bone with osteoporosis and osteoporotic fractures during therapy with recombinant erythropoietin, rosuvastatin and their combinations | Rajkumar, D. S. R.; Gudyrev, O. S.; Faitelson, A. V.; Pokrovskii, M. V. |
| 2015 | Study of the microcirculation level in bone with osteoporosis and osteoporotic fractures during therapy with recombinant erythropoietin, rosuvastatin and their combinations | Rajkumar, D. S. R.; Gudyrev, O. S.; Faitelson, A. V.; Pokrovskii, M. V. |
| 2020 | The anti-aggregation activity of new 11-amino acid of erythropoietin derivate containing tripeptide motifs | Golubev, I. V.; Gureev, V. V.; Korokina, L. V.; Gudyrev, O. S.; Pokrovskaia, T. G.; Pokopeiko, O. N. |
| 2019 | The influence of imidazoline receptor agonists on the ophthalmoscopic and morphometric parameters in retina in simulated retinal ischemia-reperfusion | Lugovskoy, S. S.; Levkova, E. A.; Bashuk, V. V.; Dubovtsova, E. Yu.; Dolzhikova, I. N.; Vain, D. S.; Gudyrev, O. S.; Korokin, M. V. |
| 2018 | The results of the study of the carcinogenic properties of glucosaminylmuramyldipeptide GMDP in chronic experiments in mice and rats | Gudyrev, O. S.; Andronova, T. M.; Nesterova, E. I. |
| 2015 | The study of osteoprotective properties of nanoparticulated forms of resveratrol and losartan | Koklina, N. Y.; Gudyrev, O. S.; Faitelson, A. V. |
